phenotypeId,phenotypeName,referentConceptId,clinicalDescription,literatureReview,phenotypeNotes
138994000,Myelodysplastic syndrome,138994,"Overview: (MDS). Disease maybe part of the spectrum of acute myeloid leukemia (AML) but with lower percentage of blast cells in peripheral blood and bone marrow (by definition < 20%). It is a group of hematologic malignancies characterized by clonal hematopoesis of one or more cell lines leading to anemia, neutropenia or thrombocytopenia.Presentation: high variability but depends on underlying cell line impacted. Cytopenia related fatigure, infections, or asymptomatic.Assessment: Suspected in all patients with symptoms of anemia, infections, or bleeding/bruising.. Complete blood count/smear, bone marrow examination, iron statining to detect ring sideroblasts. Diagnosis is based on pathological examination along with cytogentic.Plan: Treat the symptomatic anemia, thrombocytopenia, recurrent infections. Rx with granulocyte CSF and granulocyte-macrophage CSF may be beneficial in somePrognosis: Chronic disease where progression to bone marrow failure has poor prognosis.",NA,NA
